XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenues:    
Total revenues $ 32,127 $ 26,174
Cost of revenues:    
Total cost of revenues 15,963 10,549
Gross profit 16,164 15,625
Operating expenses:    
Research and development 21,448 13,700
Sales and marketing 5,239 4,789
General and administrative 13,389 8,936
Total operating expenses 40,076 27,425
Loss from operations (23,912) (11,800)
Other (expense) income:    
Loss on equity investments (1,781)  
Change in fair value 24,824 (3,079)
Interest income 420 699
Total other income (expense) 23,463 (2,380)
Loss before income taxes (449) (14,180)
Income tax expense 74 91
Net loss (523) (14,271)
Net loss attributable to noncontrolling interest (494) (445)
Net loss attributable to Schrödinger common and limited common stockholders $ (29) $ (13,826)
Net loss per share attributable to Schrödinger common and limited common stockholders, basic and diluted: $ 0.00 $ (0.34)
Weighted average shares used to compute net loss per share attributable to Schrödinger common and limited common stockholders, basic and diluted: 70,071,625 40,666,970
Software Products and Services    
Revenues:    
Total revenues $ 26,340 $ 23,812
Cost of revenues:    
Total cost of revenues 5,906 4,001
Drug Discovery    
Revenues:    
Total revenues 5,787 2,362
Cost of revenues:    
Total cost of revenues $ 10,057 $ 6,548